# Padeliporfin VTP Using Robotic Assisted Bronchoscopy in Peripheral Lung Cancer

> **NCT05918783** · PHASE1 · RECRUITING · sponsor: **Impact Biotech Ltd** · enrollment: 36 (estimated)

## Conditions studied

- Peripheral Lung Tumor

## Interventions

- **COMBINATION_PRODUCT:** Padeliporfin Vascular Targeted Photodynamic (VTP) therapy

## Key facts

- **NCT ID:** NCT05918783
- **Lead sponsor:** Impact Biotech Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-28
- **Primary completion:** 2027-05-30
- **Final completion:** 2028-12-30
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2025-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05918783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05918783, "Padeliporfin VTP Using Robotic Assisted Bronchoscopy in Peripheral Lung Cancer". Retrieved via AI Analytics 2026-09-22 from https://api.ai-analytics.org/clinical/NCT05918783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*